| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |